AlphaCentric Advisors LLC
- SEC CIK
- 0001913464
- Latest filing
- Jul 24, 2026
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Oct 30, 2024. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 230
- +13 vs. Q2 2024
- Portfolio value
- $134.5M
- −$1.28M (−0.9%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RITMRithm Capital Corp. | REIT | 380,966 | $4.32M | 3.2% | 00.0% | Unchanged | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 97,000 | $3.88M | 2.9% | −25,000−20.5% | Reduced | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 108,500 | $3.12M | 2.3% | 00.0% | Unchanged | History |
| MRKMerck & Co., Inc. | Stock | 24,000 | $2.73M | 2.0% | +24,000 | New | History |
| EFCEllington Financial Inc. | COM | 201,602 | $2.60M | 1.9% | 00.0% | Unchanged | History |
| NBIXNeurocrine Biosciences Inc | Stock | 22,500 | $2.59M | 1.9% | +15,500+221.4% | Added | History |
| MTGMgic Investment Corp | COM | 99,379 | $2.54M | 1.9% | −15,000−13.1% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 4,500 | $2.44M | 1.8% | −2,750−37.9% | Reduced | History |
| INDVIndivior Pharmaceuticals, Inc. | ORD | 242,500 | $2.36M | 1.8% | +242,500 | New | History |
| DXDynex Capital Inc | COM | 181,492 | $2.32M | 1.7% | 00.0% | Unchanged | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 32,500 | $2.28M | 1.7% | +16,000+97.0% | Added | History |
| SRPTSarepta Therapeutics, Inc. | COM | 18,000 | $2.25M | 1.7% | +10,500+140.0% | Added | History |
| DVAXDynavax Technologies Corp | COM NEW | 201,500 | $2.24M | 1.7% | +71,500+55.0% | Added | History |
| UTHRUnited Therapeutics Corp | COM | 6,250 | $2.24M | 1.7% | −8,250−56.9% | Reduced | History |
| RWTRedwood Trust Inc | COM | 288,343 | $2.23M | 1.7% | 00.0% | Unchanged | History |
| FOLDAmicus Therapeutics, Inc. | COM | 205,000 | $2.19M | 1.6% | +2,500+1.2% | Added | History |
| MFAMfa Financial, Inc. | COM | 167,725 | $2.13M | 1.6% | 00.0% | Unchanged | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 370,000 | $2.06M | 1.5% | +370,000 | New | History |
| EXASExact Sciences Corp | COM | 30,000 | $2.04M | 1.5% | 00.0% | Unchanged | History |
| Invesco QQQ Trust Series I46090E103 | ETF | 4,182 | $2.04M | 1.5% | +925+28.4% | Added | – |
| Invesco Nasdaq 100 ETF46138G649 | ETF | 10,158 | $2.04M | 1.5% | +2,259+28.6% | Added | – |
| RPRXRoyalty Pharma plc | SHS CLASS A | 67,500 | $1.91M | 1.4% | +7,500+12.5% | Added | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 45,000 | $1.75M | 1.3% | −19,000−29.7% | Reduced | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 15,500 | $1.73M | 1.3% | +4,500+40.9% | Added | History |
| MITTTPG Mortgage Investment Trust, Inc. | COM NEW | 208,879 | $1.57M | 1.2% | 00.0% | Unchanged | History |
| ACTEnact Holdings, Inc. | COM | 42,367 | $1.54M | 1.1% | 00.0% | Unchanged | History |
| ELSEquity Lifestyle Properties Inc | COM | 20,611 | $1.47M | 1.1% | 00.0% | Unchanged | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 20,000 | $1.46M | 1.1% | 00.0% | Unchanged | History |
| AMPHAmphastar Pharmaceuticals, Inc. | COM | 30,000 | $1.46M | 1.1% | +5,000+20.0% | Added | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 50,000 | $1.44M | 1.1% | −6,000−10.7% | Reduced | History |
| GSKGSK plc | ADR | 35,000 | $1.43M | 1.1% | 00.0% | Unchanged | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 47,500 | $1.37M | 1.0% | +47,500 | New | History |
| ADAMAdamas Trust, Inc. | COM | 200,963 | $1.27M | 0.9% | 00.0% | Unchanged | History |
| RVNCRevance Therapeutics, Inc. | COM | 245,000 | $1.27M | 0.9% | 00.0% | Unchanged | History |
| ONCBeOne Medicines Ltd. | ADR | 5,500 | $1.23M | 0.9% | −9,500−63.3% | Reduced | History |
| STXSStereotaxis, Inc. | COM NEW | 600,000 | $1.22M | 0.9% | 00.0% | Unchanged | History |
| ENOVEnovis CORP | COM | 27,500 | $1.18M | 0.9% | +7,500+37.5% | Added | History |
| Two HBRS Invt Corp90187BAB7 | NOTE 6.250% 1/1 | 1,205,000 | $1.18M | 0.9% | 00.0% | Unchanged | – |
| ROIVRoivant Sciences Ltd. | SHS | 100,000 | $1.15M | 0.9% | +12,000+13.6% | Added | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 26,000 | $1.14M | 0.8% | 00.0% | Unchanged | History |
| TAKTakeda Pharmaceutical Co Ltd | ADR | 80,000 | $1.14M | 0.8% | +80,000 | New | History |
| PTGXProtagonist Therapeutics, Inc | COM | 25,000 | $1.13M | 0.8% | 00.0% | Unchanged | History |
| CATXPerspective Therapeutics, Inc. | COM NEW | 80,000 | $1.07M | 0.8% | −2,000−2.4% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 30,000 | $1.02M | 0.8% | −17,500−36.8% | Reduced | History |
| PFEPfizer Inc | Stock | 35,000 | $1.01M | 0.8% | −105,000−75.0% | Reduced | History |
| SNYSanofi | SPONSORED ADR | 17,500 | $1.01M | 0.7% | 00.0% | Unchanged | History |
| IMVTImmunovant, Inc. | COM | 35,000 | $997.9K | 0.7% | −1,500−4.1% | Reduced | History |
| LNTHLantheus Holdings, Inc. | Stock | 9,000 | $987.8K | 0.7% | +9,000 | New | History |
| Pennymac Corp70932AAD5 | NOTE 5.500%11/0 | 965,000 | $961.4K | 0.7% | 00.0% | Unchanged | – |
| AXSMAxsome Therapeutics, Inc. | COM | 10,500 | $943.6K | 0.7% | −4,500−30.0% | Reduced | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 1,125,000 | $933.8K | 0.7% | 00.0% | Unchanged | History |
| AGNCAGNC Investment Corp. | REIT | 84,646 | $885.4K | 0.7% | 00.0% | Unchanged | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 37,500 | $848.6K | 0.6% | −22,500−37.5% | Reduced | History |
| ONITOnity Group Inc. | COM NEW | 25,567 | $816.6K | 0.6% | 00.0% | Unchanged | History |
| PENPenumbra Inc | COM | 4,000 | $777.2K | 0.6% | +4,000 | New | History |
| NVDANVIDIA Corp | Stock | 5,981 | $726.3K | 0.5% | −28−0.5% | Reduced | History |
| VALNValneva SE | SPONSORED ADS | 118,000 | $717.4K | 0.5% | +29,748+33.7% | Added | History |
| NUVLNuvalent, Inc. | COM | 7,000 | $716.1K | 0.5% | +7,000 | New | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 14,000 | $705.9K | 0.5% | +14,000 | New | History |
| CYTKCytokinetics Inc | COM NEW | 12,500 | $660.0K | 0.5% | +12,500 | New | History |
| PRCTPROCEPT BioRobotics Corp | COM | 8,000 | $641.0K | 0.5% | −2,000−20.0% | Reduced | History |
| ARAYAccuray Inc | COM | 350,000 | $630.0K | 0.5% | 00.0% | Unchanged | History |
| ACADAcadia Pharmaceuticals Inc | COM | 40,000 | $615.2K | 0.5% | −60,000−60.0% | Reduced | History |
| ISRGIntuitive Surgical Inc | COM NEW | 1,250 | $614.1K | 0.5% | −750−37.5% | Reduced | History |
| SYMSymbotic Inc. | Stock | 25,000 | $609.8K | 0.5% | +5,000+25.0% | Added | History |
| CGNXCognex Corp | COM | 15,000 | $607.5K | 0.5% | +15,000 | New | History |
| ROKRockwell Automation, Inc | Stock | 2,250 | $604.0K | 0.4% | +2,250 | New | History |
| SOUNSoundhound AI, Inc. | CLASS A COM | 125,000 | $582.5K | 0.4% | −25,000−16.7% | Reduced | History |
| HIGHartford Insurance Group, Inc. | Stock | 4,451 | $523.5K | 0.4% | −202−4.3% | Reduced | History |
| iShares Inc464286103 | MSCI AUST ETF | 19,248 | $521.8K | 0.4% | −605−3.0% | Reduced | – |
| SGMTSagimet Biosciences Inc. | COM SER A | 185,000 | $512.5K | 0.4% | 00.0% | Unchanged | History |
| EMBCEmbecta Corp. | Stock | 36,000 | $507.6K | 0.4% | −20,500−36.3% | Reduced | History |
| SNPSSynopsys Inc | COM | 1,000 | $506.4K | 0.4% | −1,000−50.0% | Reduced | History |
| YARWYarrow Bioscience, Inc. | COM | 268,485 | $504.8K | 0.4% | −42,015−13.5% | Reduced | History |
| AVAVAeroVironment Inc | COM | 2,500 | $501.3K | 0.4% | −650−20.6% | Reduced | History |
| APGEApogee Therapeutics, Inc. | COM | 8,500 | $499.3K | 0.4% | +8,500 | New | History |
| J P Morgan Exchange Traded F46641Q217 | BETABULDRS JAPAN | 8,363 | $495.8K | 0.4% | −260−3.0% | Reduced | – |
| KROSKeros Therapeutics, Inc. | COM | 8,000 | $464.6K | 0.3% | +8,000 | New | History |
| MDTMedtronic plc | Stock | 5,000 | $450.1K | 0.3% | −12,500−71.4% | Reduced | History |
| COSTCostco Wholesale Corp | Stock | 499 | $442.4K | 0.3% | −35−6.6% | Reduced | History |
| RSGRepublic Services, Inc. | COM | 2,020 | $405.7K | 0.3% | −138−6.4% | Reduced | History |
| ACGLArch Capital Group Ltd. | Stock | 3,587 | $401.3K | 0.3% | −123−3.3% | Reduced | History |
| LLoews Corp | COM | 4,953 | $391.5K | 0.3% | −273−5.2% | Reduced | History |
| JPMJPMorgan Chase & Co | Stock | 1,800 | $379.5K | 0.3% | −84−4.5% | Reduced | History |
| iShares Tr464287440 | 7-10 YR TRSY BD | 3,823 | $375.1K | 0.3% | −365−8.7% | Reduced | – |
| iShares Tr464288661 | 3 7 YR TREAS BD | 3,126 | $373.9K | 0.3% | −1,060−25.3% | Reduced | – |
| iShares Tr464287457 | 1 3 YR TREAS BD | 4,482 | $372.7K | 0.3% | −2,534−36.1% | Reduced | – |
| State Street SPDR Bloomberg Convertible Securities ETF78464A359 | ETF | 4,834 | $370.2K | 0.3% | −91−1.8% | Reduced | – |
| iShares Tr464288687 | PFD AND INCM SEC | 11,136 | $370.0K | 0.3% | −21−0.2% | Reduced | – |
| iShares Inc464286285 | JP MRGN EM HI BD | 9,401 | $366.8K | 0.3% | −45−0.5% | Reduced | – |
| iShares Tr464288281 | JPMORGAN USD EMG | 3,908 | $365.7K | 0.3% | −65−1.6% | Reduced | – |
| INSMINSMED Inc | COM PAR $.01 | 5,000 | $365.0K | 0.3% | +5,000 | New | History |
| Vanguard High Dividend Yield Index ETF921946406 | ETF | 2,815 | $360.9K | 0.3% | −121−4.1% | Reduced | – |
| Invesco Exchange Traded FD T46137V399 | S&P500 BUY WRT | 15,794 | $360.7K | 0.3% | −229−1.4% | Reduced | – |
| SPDR Index Shs FDS78463X772 | ST S&P INTL ETF | 9,375 | $360.0K | 0.3% | −589−5.9% | Reduced | – |
| DYNDyne Therapeutics, Inc. | COM | 10,000 | $359.2K | 0.3% | −10,000−50.0% | Reduced | History |
| Invesco Exch Traded FD Tr II46138G508 | SR LN ETF | 17,016 | $357.5K | 0.3% | +333+2.0% | Added | – |
| iShares Tr46435G342 | MORTGE REL ETF | 14,926 | $354.2K | 0.3% | +745+5.3% | Added | – |
| DALDelta Air Lines, Inc. | COM NEW | 6,951 | $353.0K | 0.3% | −214−3.0% | Reduced | History |
| AVBPArriVent BioPharma, Inc. | COM | 15,000 | $352.5K | 0.3% | −71,000−82.6% | Reduced | History |
Sold out since Q2 2024 (15)
Positions held at the end of Q2 2024 that are gone from this filing.
| Security | Class | Shares in Q2 2024 | Value in Q2 2024 | % of portfolio in Q2 2024 | History |
|---|---|---|---|---|---|
| BCRXBiocryst Pharmaceuticals Inc | COM | 675,000 | $4.17M | 3.1% | History |
| PCRXPacira BioSciences, Inc. | COM | 117,500 | $3.36M | 2.5% | History |
| QUREuniQure N.V. | SHS | 460,000 | $2.06M | 1.5% | History |
| DCGODocGo Inc. | COM | 650,000 | $2.01M | 1.5% | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 42,500 | $1.74M | 1.3% | History |
| RWT Hldgs Inc749772AD1 | CONVERTIBLE BOND | 1,000,000 | $975.0K | 0.7% | – |
| NARIInari Medical, Inc. | Stock | 15,000 | $722.3K | 0.5% | History |
| CABACabaletta Bio, Inc. | COM | 70,000 | $523.6K | 0.4% | History |
| Redwood Trust Inc758075AF2 | NOTE 7.750% 6/1 | 500,000 | $485.9K | 0.4% | – |
| iShares Russell 1000 Value ETF464287598 | ETF | 2,762 | $481.9K | 0.4% | – |
| Invesco Exchange Traded FD T46137V258 | S&P500 PUR VAL | 5,715 | $476.7K | 0.4% | – |
| AUPHAurinia Pharmaceuticals Inc. | COM | 80,000 | $456.8K | 0.3% | History |
| iShares Inc464286715 | MSCI TURKEY ETF | 2,894 | $121.6K | 0.1% | – |
| KALVKalVista Pharmaceuticals, Inc. | COM | 2,500 | $29.4K | <0.1% | History |
| VTYXVentyx Biosciences, Inc. | COM | 10,000 | $23.1K | <0.1% | History |